Israel Active

A joint study by Israeli and Swedish researchers has found that a plain whey protein drink one half hour before breakfast could help diabetics, or pre-diabetics, prevent blood sugar spikes and better manage the disease. Blood glucose levels were reduced, insulin levels were higher and the response was earlier.

More lives can be saved now that Israel has adopted technology to allow transplants from donors whose hearts have stopped beating. Previously, some religious authorities rejected brain-stem death, whilst cardiac death damaged vital organs making them unusable.

The exclusive International Society of Orthopedic Centers (ISOC) has expanded its membership to include one center in the Middle East: Jerusalem’s Hadassah Medical Center. ISOC members must perform a minimum of 5,000 orthopedic surgeries each year.

(Thanks to Atid-EDI) Israel’s Kadimastem is to work with giant Merck to conduct screening for new treatments into Multiple Sclerosis and other neurodegenerative diseases. Kadimastem’s revolutionary technology uses stem cells to produce cells that protect or repair brain function.

Dr. Svetlana Bunimovich of Ariel University has developed mathematical models to improve the treatment of bladder cancer. She was inspired to study the issue when her mother was diagnosed with bladder cancer.

Soldiers wounded in Operation Protective Edge are benefiting from a brand-new Israeli technology to close open wounds quickly. TopClosure acts like a medical zip to protect wounds immediately when they are inflicted, allowing them to be fully treated later.

Electronic Medical Records transformed Israel’s health system and convinced the USA to implement them. Sensing technology is the next big advance. Jerusalem’s symposium “Connected Health and Vulnerable Populations” showed how Israel is a prototype for global better health.

ALS sufferers live longer in Israel.  In global terms, between 5 and 10 percent of ALS sufferers survive more than 10 years after being diagnosed. But in Israel, 20 percent of ALS patients survive longer.  The high survival rate is thought to be due to family support systems, the Israeli health care system and early diagnosis.  (link expired) (link should work)  

Israel’s BrainStorm, together with Canadian company Octane Biotech, has built a bioreactor for commercial production of the stem cells used as a basis for the company's treatment for ALCS. The ability to multiply stem cells is critical for the treatment's success.

Virologist Dr. Leslie Lobel from Ben Gurion University is developing a vaccine to defeat the Ebola virus by studying the immune systems of the disease’s survivors. He has spent 12 years studying the disease in Uganda.